1. Home
  2. KMDA vs NFBK Comparison

KMDA vs NFBK Comparison

Compare KMDA & NFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • NFBK
  • Stock Information
  • Founded
  • KMDA 1990
  • NFBK 1887
  • Country
  • KMDA Israel
  • NFBK United States
  • Employees
  • KMDA N/A
  • NFBK N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • NFBK Major Banks
  • Sector
  • KMDA Health Care
  • NFBK Finance
  • Exchange
  • KMDA Nasdaq
  • NFBK Nasdaq
  • Market Cap
  • KMDA 398.5M
  • NFBK 454.5M
  • IPO Year
  • KMDA N/A
  • NFBK 2007
  • Fundamental
  • Price
  • KMDA $6.95
  • NFBK $10.43
  • Analyst Decision
  • KMDA Strong Buy
  • NFBK Hold
  • Analyst Count
  • KMDA 2
  • NFBK 3
  • Target Price
  • KMDA $13.00
  • NFBK $12.67
  • AVG Volume (30 Days)
  • KMDA 77.7K
  • NFBK 200.9K
  • Earning Date
  • KMDA 11-12-2025
  • NFBK 10-22-2025
  • Dividend Yield
  • KMDA 2.88%
  • NFBK 4.82%
  • EPS Growth
  • KMDA 27.97
  • NFBK 51.92
  • EPS
  • KMDA 0.32
  • NFBK 0.97
  • Revenue
  • KMDA $169,517,000.00
  • NFBK $141,983,000.00
  • Revenue This Year
  • KMDA $14.49
  • NFBK $8.04
  • Revenue Next Year
  • KMDA $10.12
  • NFBK $17.33
  • P/E Ratio
  • KMDA $21.01
  • NFBK $11.09
  • Revenue Growth
  • KMDA 9.67
  • NFBK 13.99
  • 52 Week Low
  • KMDA $5.43
  • NFBK $9.40
  • 52 Week High
  • KMDA $9.16
  • NFBK $14.39
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 52.44
  • NFBK 36.96
  • Support Level
  • KMDA $6.72
  • NFBK $10.61
  • Resistance Level
  • KMDA $7.11
  • NFBK $11.24
  • Average True Range (ATR)
  • KMDA 0.19
  • NFBK 0.38
  • MACD
  • KMDA 0.03
  • NFBK -0.05
  • Stochastic Oscillator
  • KMDA 60.68
  • NFBK 15.08

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About NFBK Northfield Bancorp Inc. (Delaware)

Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.

Share on Social Networks: